{"id":6980,"date":"2025-12-10T18:28:42","date_gmt":"2025-12-10T18:28:42","guid":{"rendered":"https:\/\/bristishpharmacy.co.uk\/?post_type=product&#038;p=6980"},"modified":"2026-09-16T10:09:53","modified_gmt":"2026-09-16T10:09:53","slug":"mounjaro-5mg-kwikpen","status":"publish","type":"product","link":"https:\/\/bristishpharmacy.co.uk\/de\/shop\/mounjaro-5mg-kwikpen\/","title":{"rendered":"mounjaro 5mg kwikpen"},"content":{"rendered":"<div class=\"container\">\n<div id=\"model-response-message-contentr_15062d2951babdd8\" class=\"markdown markdown-main-panel md-content enable-luminous-fast-follows enable-updated-hr-color stronger tutor-markdown-rendering\" dir=\"ltr\" aria-live=\"polite\">\n<h3 data-path-to-node=\"3\">Clinical Monograph: Mounjaro 5 mg KwikPen (Tirzepatide)<\/h3>\n<div class=\"attachment-container search-images\">\n<div class=\"image-container spark-licensed-center hide-from-message-actions ng-star-inserted\" data-full-size-image-uri=\"https:\/\/images.apollo247.in\/pub\/media\/catalog\/product\/m\/o\/mou0070-1_2__1.jpg\">\n<div class=\"overlay-container hero-overlay-container ng-star-inserted\"><button class=\"image-button ng-star-inserted\"><img fetchpriority=\"high\" decoding=\"async\" class=\"spark-licensed-portrait hero-image loaded\" src=\"https:\/\/encrypted-tbn0.gstatic.com\/images?q=tbn:ANd9GcRH3Q44LxyYfe02a0uWIGSSF6Ty7gYDfmi0IIS5UNPAU8A-8U6pshnkwMYt&amp;s=10\" alt=\"Mounjaro 5 mg KwikPen pre-filled injection pen, AI generated\" width=\"265\" height=\"377\" \/><\/button><\/p>\n<div class=\"hero-caption-row ng-star-inserted\">\n<div class=\"caption gds-extended-caption hero-caption ng-star-inserted\" aria-hidden=\"true\">Mounjaro 5 mg KwikPen pre-filled injection pen. <span class=\"ng-star-inserted\">Source: Apollo Pharmacy<\/span><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<h2 data-path-to-node=\"5\">1. Classification and Chemical Overview<\/h2>\n<p data-path-to-node=\"6\">Tirzepatide is a synthetic 39-amino-acid peptide engineered with a <span class=\"math-inline\" data-math=\"C_{20}\" data-index-in-node=\"67\"><span class=\"katex\"><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mord\"><span class=\"mord mathnormal\">C<\/span><span class=\"msupsub\"><span class=\"vlist-t vlist-t2\"><span class=\"vlist-r\"><span class=\"vlist\"><span class=\"\"><span class=\"sizing reset-size6 size3 mtight\"><span class=\"mord mtight\">20<\/span><\/span><\/span><\/span><span class=\"vlist-s\">\u200b<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span> fatty diacid diacid-acyl chain moiety attached via a linker to lysine at position 20. It belongs to a novel therapeutic class: <b data-path-to-node=\"6\" data-index-in-node=\"201\">dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists<\/b> (&#8220;twincretins&#8221;). Under the Anatomical Therapeutic Chemical (ATC) classification system, tirzepatide is indexed under A10BX16.<\/p>\n<p data-path-to-node=\"7\">The <b data-path-to-node=\"7\" data-index-in-node=\"4\">Mounjaro KwikPen<\/b> is a multi-dose pre-filled pen containing 2.4 mL of solution (<span class=\"math-inline\" data-math=\"8.33\\text{ mg\/mL}\" data-index-in-node=\"83\"><span class=\"katex\"><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mord\">8.33<\/span><span class=\"mord text\"><span class=\"mord\">\u00a0mg\/mL<\/span><\/span><\/span><\/span><\/span><\/span>) designed to deliver 4 fixed weekly doses of <b data-path-to-node=\"7\" data-index-in-node=\"146\">5 mg tirzepatide<\/b> in a 0.6 mL volume per injection. In the UK, EU, and global jurisdictions, Mounjaro is a Prescription Only Medicine (POM).<\/p>\n<h2 data-path-to-node=\"8\">2. Mechanism of Action and Pharmacodynamics<\/h2>\n<p data-path-to-node=\"9\">Tirzepatide acts as a biased dual agonist at both native GIP and GLP-1 receptors, exhibiting greater potency at GIP receptors relative to GLP-1 receptors:<\/p>\n<ul data-path-to-node=\"10\">\n<li>\n<p data-path-to-node=\"10,0,0\"><b data-path-to-node=\"10,0,0\" data-index-in-node=\"0\">GIP Receptor Activation:<\/b> Enhances glucose-dependent insulin secretion, improves postprandial glucagon dynamics, increases peripheral insulin sensitivity, and directly modulates lipid metabolism in adipose tissue.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"10,1,0\"><b data-path-to-node=\"10,1,0\" data-index-in-node=\"0\">GLP-1 Receptor Activation:<\/b> Stimulates glucose-dependent pancreatic <span class=\"math-inline\" data-math=\"\\beta\" data-index-in-node=\"67\"><span class=\"katex\"><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mord mathnormal\">\u03b2<\/span><\/span><\/span><\/span><\/span>-cell insulin exocytosis, suppresses glucagon secretion from <span class=\"math-inline\" data-math=\"\\alpha\" data-index-in-node=\"133\"><span class=\"katex\"><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mord mathnormal\">\u03b1<\/span><\/span><\/span><\/span><\/span>-cells during hyperglycaemia, slows gastric emptying, and activates central anorexigenic hypothalamic pathways to reduce appetite and energy intake.<\/p>\n<\/li>\n<\/ul>\n<p data-path-to-node=\"11\">The 5 mg weekly dose represents the primary maintenance dose following initial titration, producing significant reductions in glycated haemoglobin (<span class=\"math-inline\" data-math=\"\\text{HbA}_{1c}\" data-index-in-node=\"148\"><span class=\"katex\"><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mord\"><span class=\"mord text\">HbA<\/span><span class=\"msupsub\"><span class=\"vlist-t vlist-t2\"><span class=\"vlist-r\"><span class=\"vlist\"><span class=\"\"><span class=\"sizing reset-size6 size3 mtight\"><span class=\"mord mtight\">1<span class=\"mord mathnormal mtight\">c<\/span><\/span><\/span><\/span><\/span><span class=\"vlist-s\">\u200b<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span>) and clinically meaningful body weight loss.<\/p>\n<h2 data-path-to-node=\"12\">3. Approved Clinical Indications and Therapeutic Scope<\/h2>\n<p data-path-to-node=\"13\">Licensing for Mounjaro 5 mg KwikPen includes:<\/p>\n<ul data-path-to-node=\"14\">\n<li>\n<p data-path-to-node=\"14,0,0\"><b data-path-to-node=\"14,0,0\" data-index-in-node=\"0\">Type 2 Diabetes Mellitus:<\/b> Treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise (as monotherapy when metformin is considered inappropriate, or as add-on therapy to other anti-hyperglycaemic medicinal products).<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"14,1,0\"><b data-path-to-node=\"14,1,0\" data-index-in-node=\"0\">Weight Management:<\/b> Adjunct to a reduced-calorie diet and increased physical activity for weight management in adults with:<\/p>\n<ul data-path-to-node=\"14,1,1\">\n<li>\n<p data-path-to-node=\"14,1,1,0,0\">An initial BMI of <span class=\"math-inline\" data-math=\"\\ge 30\\text{ kg\/m}^2\" data-index-in-node=\"18\"><span class=\"katex\"><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mrel\">\u2265<\/span><\/span><span class=\"base\"><span class=\"mord\">30<\/span><span class=\"mord\"><span class=\"mord text\">\u00a0kg\/m<\/span><span class=\"msupsub\"><span class=\"vlist-t\"><span class=\"vlist-r\"><span class=\"vlist\"><span class=\"\"><span class=\"sizing reset-size6 size3 mtight\"><span class=\"mord mtight\">2<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span> (obesity), or<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"14,1,1,1,0\">An initial BMI of <span class=\"math-inline\" data-math=\"\\ge 27\\text{ kg\/m}^2\\text{ to }&lt; 30\\text{ kg\/m}^2\" data-index-in-node=\"18\"><span class=\"katex\"><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mrel\">\u2265<\/span><\/span><span class=\"base\"><span class=\"mord\">27<\/span><span class=\"mord\"><span class=\"mord text\">\u00a0kg\/m<\/span><span class=\"msupsub\"><span class=\"vlist-t\"><span class=\"vlist-r\"><span class=\"vlist\"><span class=\"\"><span class=\"sizing reset-size6 size3 mtight\"><span class=\"mord mtight\">2<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><span class=\"mord text\"><span class=\"mord\">\u00a0to\u00a0<\/span><\/span><span class=\"mrel\">&lt;<\/span><\/span><span class=\"base\"><span class=\"mord\">30<\/span><span class=\"mord\"><span class=\"mord text\">\u00a0kg\/m<\/span><span class=\"msupsub\"><span class=\"vlist-t\"><span class=\"vlist-r\"><span class=\"vlist\"><span class=\"\"><span class=\"sizing reset-size6 size3 mtight\"><span class=\"mord mtight\">2<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span> (overweight) in the presence of at least one weight-related comorbidity (e.g., hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease).<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p data-path-to-node=\"15\"><i data-path-to-node=\"15\" data-index-in-node=\"0\">Dosing &amp; Escalation Regimen:<\/i> Therapy is initiated at 2.5 mg once weekly for 4 weeks. At week 5, the dosage is escalated to the <b data-path-to-node=\"15\" data-index-in-node=\"127\">5 mg once weekly maintenance dose<\/b>. Depending on clinical response and tolerability, doses may be increased in 2.5 mg increments after at least 4 weeks on a given dose (up to a maximum of 15 mg once weekly).<\/p>\n<h2 data-path-to-node=\"16\">4. Pharmacokinetic Profile and Metabolic Fate<\/h2>\n<ul data-path-to-node=\"17\">\n<li>\n<p data-path-to-node=\"17,0,0\"><b data-path-to-node=\"17,0,0\" data-index-in-node=\"0\">Absorption:<\/b> Absolute bio-availability following subcutaneous injection is approximately 80%. Peak plasma concentration (<span class=\"math-inline\" data-math=\"C_{max}\" data-index-in-node=\"120\"><span class=\"katex\"><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mord\"><span class=\"mord mathnormal\">C<\/span><span class=\"msupsub\"><span class=\"vlist-t vlist-t2\"><span class=\"vlist-r\"><span class=\"vlist\"><span class=\"\"><span class=\"sizing reset-size6 size3 mtight\"><span class=\"mord mtight\"><span class=\"mord mathnormal mtight\">ma<\/span><span class=\"mord mathnormal mtight\">x<\/span><\/span><\/span><\/span><\/span><span class=\"vlist-s\">\u200b<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span>) occurs between 8 and 72 hours (<span class=\"math-inline\" data-math=\"T_{max}\" data-index-in-node=\"160\"><span class=\"katex\"><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mord\"><span class=\"mord mathnormal\">T<\/span><span class=\"msupsub\"><span class=\"vlist-t vlist-t2\"><span class=\"vlist-r\"><span class=\"vlist\"><span class=\"\"><span class=\"sizing reset-size6 size3 mtight\"><span class=\"mord mtight\"><span class=\"mord mathnormal mtight\">ma<\/span><span class=\"mord mathnormal mtight\">x<\/span><\/span><\/span><\/span><\/span><span class=\"vlist-s\">\u200b<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span>) post-dose.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"17,1,0\"><b data-path-to-node=\"17,1,0\" data-index-in-node=\"0\">Distribution:<\/b> Tirzepatide is extensively bound to plasma proteins (99%, primarily human serum albumin). Mean volume of distribution (<span class=\"math-inline\" data-math=\"V_d\" data-index-in-node=\"133\"><span class=\"katex\"><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mord\"><span class=\"mord mathnormal\">V<\/span><span class=\"msupsub\"><span class=\"vlist-t vlist-t2\"><span class=\"vlist-r\"><span class=\"vlist\"><span class=\"\"><span class=\"sizing reset-size6 size3 mtight\"><span class=\"mord mathnormal mtight\">d<\/span><\/span><\/span><\/span><span class=\"vlist-s\">\u200b<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span>) is approximately <span class=\"math-inline\" data-math=\"9.5\\text{ L}\" data-index-in-node=\"155\"><span class=\"katex\"><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mord\">9.5<\/span><span class=\"mord text\"><span class=\"mord\">\u00a0L<\/span><\/span><\/span><\/span><\/span><\/span>.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"17,2,0\"><b data-path-to-node=\"17,2,0\" data-index-in-node=\"0\">Biotransformation:<\/b> Tirzepatide is metabolised via proteolytic cleavage of the peptide backbone, <span class=\"math-inline\" data-math=\"\\beta\" data-index-in-node=\"96\"><span class=\"katex\"><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mord mathnormal\">\u03b2<\/span><\/span><\/span><\/span><\/span>-oxidation of the <span class=\"math-inline\" data-math=\"C_{20}\" data-index-in-node=\"119\"><span class=\"katex\"><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mord\"><span class=\"mord mathnormal\">C<\/span><span class=\"msupsub\"><span class=\"vlist-t vlist-t2\"><span class=\"vlist-r\"><span class=\"vlist\"><span class=\"\"><span class=\"sizing reset-size6 size3 mtight\"><span class=\"mord mtight\">20<\/span><\/span><\/span><\/span><span class=\"vlist-s\">\u200b<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span> fatty acid moiety, and amide hydrolysis. It does not significantly inhibit or induce Cytochrome P450 (CYP) enzymes.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"17,3,0\"><b data-path-to-node=\"17,3,0\" data-index-in-node=\"0\">Elimination:<\/b> Clearance is approximately <span class=\"math-inline\" data-math=\"0.06\\text{ L\/h}\" data-index-in-node=\"40\"><span class=\"katex\"><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mord\">0.06<\/span><span class=\"mord text\"><span class=\"mord\">\u00a0L\/h<\/span><\/span><\/span><\/span><\/span><\/span>, with an elimination half-life (<span class=\"math-inline\" data-math=\"t_{1\/2}\" data-index-in-node=\"88\"><span class=\"katex\"><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mord\"><span class=\"mord mathnormal\">t<\/span><span class=\"msupsub\"><span class=\"vlist-t vlist-t2\"><span class=\"vlist-r\"><span class=\"vlist\"><span class=\"\"><span class=\"sizing reset-size6 size3 mtight\"><span class=\"mord mtight\">1\/2<\/span><\/span><\/span><\/span><span class=\"vlist-s\">\u200b<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span>) of approximately 5 days (120 hours), supporting once-weekly subcutaneous dosing. Metabolites are excreted via urine and faeces.<\/p>\n<\/li>\n<\/ul>\n<h2 data-path-to-node=\"18\">5. Physiological Effects and Adverse Event Spectrum<\/h2>\n<p data-path-to-node=\"19\">Tirzepatide improves overall glucose homeostasis, decreases fasting and postprandial glucose levels, delays gastric transit, and reduces total fat mass.<\/p>\n<h3 data-path-to-node=\"20\">Adverse Drug Reaction Spectrum<\/h3>\n<ul data-path-to-node=\"21\">\n<li>\n<p data-path-to-node=\"21,0,0\"><b data-path-to-node=\"21,0,0\" data-index-in-node=\"0\">Very Common (<span class=\"math-inline\" data-math=\"\\ge 1\/10\" data-index-in-node=\"13\"><span class=\"katex\"><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mrel\">\u2265<\/span><\/span><span class=\"base\"><span class=\"mord\">1\/10<\/span><\/span><\/span><\/span><\/span>):<\/b> Nausea, diarrhoea, vomiting, constipation, hypoglycaemia (when used in combination with sulfonylureas or insulin).<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"21,1,0\"><b data-path-to-node=\"21,1,0\" data-index-in-node=\"0\">Common (<span class=\"math-inline\" data-math=\"\\ge 1\/100\" data-index-in-node=\"8\"><span class=\"katex\"><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mrel\">\u2265<\/span><\/span><span class=\"base\"><span class=\"mord\">1\/100<\/span><\/span><\/span><\/span><\/span> to <span class=\"math-inline\" data-math=\"&lt;1\/10\" data-index-in-node=\"21\"><span class=\"katex\"><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mrel\">&lt;<\/span><\/span><span class=\"base\"><span class=\"mord\">1\/10<\/span><\/span><\/span><\/span><\/span>):<\/b> Dyspepsia, abdominal pain, abdominal distension, eructation, flatulence, gastro-oesophageal reflux disease, fatigue, injection site reactions (erythema, pruritus), hair loss (alopecia), sinus tachycardia.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"21,2,0\"><b data-path-to-node=\"21,2,0\" data-index-in-node=\"0\">Uncommon (<span class=\"math-inline\" data-math=\"\\ge 1\/1,000\" data-index-in-node=\"10\"><span class=\"katex\"><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mrel\">\u2265<\/span><\/span><span class=\"base\"><span class=\"mord\">1\/1<\/span><span class=\"mpunct\">,<\/span><span class=\"mord\">000<\/span><\/span><\/span><\/span><\/span> to <span class=\"math-inline\" data-math=\"&lt;1\/100\" data-index-in-node=\"25\"><span class=\"katex\"><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mrel\">&lt;<\/span><\/span><span class=\"base\"><span class=\"mord\">1\/100<\/span><\/span><\/span><\/span><\/span>):<\/b> Acute pancreatitis, cholelithiasis, cholecystitis, elevated pancreatic enzymes (lipase, amylase), dysgeusia, delayed gastric emptying.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"21,3,0\"><b data-path-to-node=\"21,3,0\" data-index-in-node=\"0\">Rare (&lt;1\/1,000):<\/b> Anaphylactic reactions, angioedema.<\/p>\n<\/li>\n<\/ul>\n<h2 data-path-to-node=\"22\">6. Contraindications, Drug Interactions, and Clinical Precautions<\/h2>\n<h3 data-path-to-node=\"23\">Kontraindikationen<\/h3>\n<ul data-path-to-node=\"24\">\n<li>\n<p data-path-to-node=\"24,0,0\">Hypersensitivity to tirzepatide or any of the formulation excipients.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"24,1,0\">Personal or family history of Medullary Thyroid Carcinoma (MTC).<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"24,2,0\">Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).<\/p>\n<\/li>\n<\/ul>\n<h3 data-path-to-node=\"25\">Key Drug Interactions<\/h3>\n<ul data-path-to-node=\"26\">\n<li>\n<p data-path-to-node=\"26,0,0\"><b data-path-to-node=\"26,0,0\" data-index-in-node=\"0\">Oral Medications with Narrow Therapeutic Index:<\/b> Due to tirzepatide-induced delay in gastric emptying, the rate and extent of absorption of concomitantly administered oral medicinal products (e.g., warfarin, digoxin) may be transiently altered, particularly during dose initiation and escalation.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"26,1,0\"><b data-path-to-node=\"26,1,0\" data-index-in-node=\"0\">Oral Contraceptives:<\/b> Patients using oral hormonal contraceptives should be advised to switch to a non-hormonal contraceptive method, or add a barrier method, for 4 weeks after initiation and for 4 weeks after each dose escalation.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"26,2,0\"><b data-path-to-node=\"26,2,0\" data-index-in-node=\"0\">Insulin and Sulfonylureas:<\/b> Increased risk of severe hypoglycaemia. A reduction in the dose of secretagogues or insulin may be required upon initiating or stepping up Mounjaro therapy.<\/p>\n<\/li>\n<\/ul>\n<h3 data-path-to-node=\"27\">Clinical Precautions and Monitoring<\/h3>\n<ul data-path-to-node=\"28\">\n<li>\n<p data-path-to-node=\"28,0,0\"><b data-path-to-node=\"28,0,0\" data-index-in-node=\"0\">Gastrointestinal Disease:<\/b> Tirzepatide has not been studied in patients with severe gastrointestinal disease, including severe gastroparesis, and should be used with caution.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"28,1,0\"><b data-path-to-node=\"28,1,0\" data-index-in-node=\"0\">Acute Pancreatitis:<\/b> Patients should be monitored for signs of acute pancreatitis (persistent, severe abdominal pain radiating to the back). If suspected, treatment must be permanently discontinued.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"28,2,0\"><b data-path-to-node=\"28,2,0\" data-index-in-node=\"0\">Renal Impairment &amp; Dehydration:<\/b> Gastrointestinal adverse reactions (vomiting, diarrhoea) may lead to volume depletion and acute kidney injury. Patients should be advised to maintain adequate hydration.<\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n    <div class=\"xs_social_share_widget xs_share_url after_content \t\tmain_content  wslu-style-1 wslu-share-box-shaped wslu-fill-colored wslu-none wslu-share-horizontal wslu-theme-font-no wslu-main_content\">\n\n\t\t\n        <ul>\n\t\t\t        <\/ul>\n    <\/div>","protected":false},"excerpt":{"rendered":"<p data-path-to-node=\"1\">Mounjaro 5 mg KwikPen (tirzepatide) is a once-weekly multi-dose pre-filled injection pen indicated for glycemic control in adults with type 2 diabetes and chronic weight management in adults with obesity or overweight with weight-related comorbidities.<\/p>\n<h3 data-path-to-node=\"3\">\u00a0<\/h3>","protected":false},"featured_media":6987,"comment_status":"closed","ping_status":"closed","template":"","meta":{"postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""}},"product_brand":[],"product_cat":[105],"product_tag":[115,114],"class_list":["post-6980","product","type-product","status-publish","has-post-thumbnail","product_cat-weight-loss","product_tag-mounjaro-5mg-kwikpen","product_tag-tirzepatide","instock","shipping-taxable","purchasable","product-type-variable"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.5 (Yoast SEO v28.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>mounjaro 5mg kwikpen - British Pharmacy<\/title>\n<meta name=\"description\" content=\"Mounjaro 5mg KwikPen is revolutionizing the treatment of type 2 diabetes and obesity. As a once-weekly injectable medication,\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bristishpharmacy.co.uk\/de\/shop\/mounjaro-5mg-kwikpen\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"mounjaro 5mg kwikpen\" \/>\n<meta property=\"og:description\" content=\"Mounjaro 5 mg KwikPen (tirzepatide) is a once-weekly multi-dose pre-filled injection pen indicated for glycemic control in adults with type 2 diabetes and chronic weight management in adults with obesity or overweight with weight-related comorbidities.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bristishpharmacy.co.uk\/de\/shop\/mounjaro-5mg-kwikpen\/\" \/>\n<meta property=\"og:site_name\" content=\"British Pharmacy\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-16T10:09:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bristishpharmacy.co.uk\/wp-content\/uploads\/2025\/12\/5028776933021387677.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"480\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/shop\\\/mounjaro-5mg-kwikpen\\\/\",\"url\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/shop\\\/mounjaro-5mg-kwikpen\\\/\",\"name\":\"mounjaro 5mg kwikpen - British Pharmacy\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/shop\\\/mounjaro-5mg-kwikpen\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/shop\\\/mounjaro-5mg-kwikpen\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/5028776933021387677.jpg\",\"datePublished\":\"2025-12-10T18:28:42+00:00\",\"dateModified\":\"2026-09-16T10:09:53+00:00\",\"description\":\"Mounjaro 5mg KwikPen is revolutionizing the treatment of type 2 diabetes and obesity. As a once-weekly injectable medication,\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/shop\\\/mounjaro-5mg-kwikpen\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/bristishpharmacy.co.uk\\\/shop\\\/mounjaro-5mg-kwikpen\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/shop\\\/mounjaro-5mg-kwikpen\\\/#primaryimage\",\"url\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/5028776933021387677.jpg\",\"contentUrl\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/5028776933021387677.jpg\",\"width\":500,\"height\":480,\"caption\":\"Mounjaro Kwikpen Needles\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/shop\\\/mounjaro-5mg-kwikpen\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shop\",\"item\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/shop\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"mounjaro 5mg kwikpen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/#website\",\"url\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/\",\"name\":\"British Pharmacy\",\"description\":\"Order Medication &amp; Pills Online\",\"publisher\":{\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/#organization\",\"name\":\"British Pharma\",\"url\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/Site-icon.png\",\"contentUrl\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/Site-icon.png\",\"width\":513,\"height\":513,\"caption\":\"British Pharma\"},\"image\":{\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"mounjaro 5mg kwikpen - British Pharmacy","description":"Mounjaro 5mg KwikPen revolutioniert die Behandlung von Typ-2-diabetes und Adipositas. Als einmal w\u00f6chentlich injizierbare Medikamente,","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bristishpharmacy.co.uk\/de\/shop\/mounjaro-5mg-kwikpen\/","og_locale":"de_DE","og_type":"article","og_title":"mounjaro 5mg kwikpen","og_description":"Mounjaro 5 mg KwikPen (tirzepatide) is a once-weekly multi-dose pre-filled injection pen indicated for glycemic control in adults with type 2 diabetes and chronic weight management in adults with obesity or overweight with weight-related comorbidities.\u00a0","og_url":"https:\/\/bristishpharmacy.co.uk\/de\/shop\/mounjaro-5mg-kwikpen\/","og_site_name":"British Pharmacy","article_modified_time":"2026-09-16T10:09:53+00:00","og_image":[{"width":500,"height":480,"url":"https:\/\/bristishpharmacy.co.uk\/wp-content\/uploads\/2025\/12\/5028776933021387677.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/bristishpharmacy.co.uk\/shop\/mounjaro-5mg-kwikpen\/","url":"https:\/\/bristishpharmacy.co.uk\/shop\/mounjaro-5mg-kwikpen\/","name":"mounjaro 5mg kwikpen - British Pharmacy","isPartOf":{"@id":"https:\/\/bristishpharmacy.co.uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/bristishpharmacy.co.uk\/shop\/mounjaro-5mg-kwikpen\/#primaryimage"},"image":{"@id":"https:\/\/bristishpharmacy.co.uk\/shop\/mounjaro-5mg-kwikpen\/#primaryimage"},"thumbnailUrl":"https:\/\/bristishpharmacy.co.uk\/wp-content\/uploads\/2025\/12\/5028776933021387677.jpg","datePublished":"2025-12-10T18:28:42+00:00","dateModified":"2026-09-16T10:09:53+00:00","description":"Mounjaro 5mg KwikPen revolutioniert die Behandlung von Typ-2-diabetes und Adipositas. Als einmal w\u00f6chentlich injizierbare Medikamente,","breadcrumb":{"@id":"https:\/\/bristishpharmacy.co.uk\/shop\/mounjaro-5mg-kwikpen\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bristishpharmacy.co.uk\/shop\/mounjaro-5mg-kwikpen\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/bristishpharmacy.co.uk\/shop\/mounjaro-5mg-kwikpen\/#primaryimage","url":"https:\/\/bristishpharmacy.co.uk\/wp-content\/uploads\/2025\/12\/5028776933021387677.jpg","contentUrl":"https:\/\/bristishpharmacy.co.uk\/wp-content\/uploads\/2025\/12\/5028776933021387677.jpg","width":500,"height":480,"caption":"Mounjaro Kwikpen Needles"},{"@type":"BreadcrumbList","@id":"https:\/\/bristishpharmacy.co.uk\/shop\/mounjaro-5mg-kwikpen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bristishpharmacy.co.uk\/"},{"@type":"ListItem","position":2,"name":"Shop","item":"https:\/\/bristishpharmacy.co.uk\/shop\/"},{"@type":"ListItem","position":3,"name":"mounjaro 5mg kwikpen"}]},{"@type":"WebSite","@id":"https:\/\/bristishpharmacy.co.uk\/#website","url":"https:\/\/bristishpharmacy.co.uk\/","name":"British Pharmacy","description":"Order Medication &amp; Pills Online","publisher":{"@id":"https:\/\/bristishpharmacy.co.uk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bristishpharmacy.co.uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/bristishpharmacy.co.uk\/#organization","name":"British Pharma","url":"https:\/\/bristishpharmacy.co.uk\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/bristishpharmacy.co.uk\/#\/schema\/logo\/image\/","url":"https:\/\/bristishpharmacy.co.uk\/wp-content\/uploads\/2026\/09\/Site-icon.png","contentUrl":"https:\/\/bristishpharmacy.co.uk\/wp-content\/uploads\/2026\/09\/Site-icon.png","width":513,"height":513,"caption":"British Pharma"},"image":{"@id":"https:\/\/bristishpharmacy.co.uk\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/bristishpharmacy.co.uk\/de\/wp-json\/wp\/v2\/product\/6980","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bristishpharmacy.co.uk\/de\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/bristishpharmacy.co.uk\/de\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/bristishpharmacy.co.uk\/de\/wp-json\/wp\/v2\/comments?post=6980"}],"version-history":[{"count":5,"href":"https:\/\/bristishpharmacy.co.uk\/de\/wp-json\/wp\/v2\/product\/6980\/revisions"}],"predecessor-version":[{"id":10727,"href":"https:\/\/bristishpharmacy.co.uk\/de\/wp-json\/wp\/v2\/product\/6980\/revisions\/10727"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bristishpharmacy.co.uk\/de\/wp-json\/wp\/v2\/media\/6987"}],"wp:attachment":[{"href":"https:\/\/bristishpharmacy.co.uk\/de\/wp-json\/wp\/v2\/media?parent=6980"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/bristishpharmacy.co.uk\/de\/wp-json\/wp\/v2\/product_brand?post=6980"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/bristishpharmacy.co.uk\/de\/wp-json\/wp\/v2\/product_cat?post=6980"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/bristishpharmacy.co.uk\/de\/wp-json\/wp\/v2\/product_tag?post=6980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}